Juvabis AG is a clinical stage biotech company developing the next generation of aminoglycoside antibiotics. Its first-in-class human therapeutic portfolio demonstrates preclinical safety and efficacy in critical systemic infections by highly drug-resistant Gram-negative pathogens and mycobacteria.

Location

Schützengasse 1, 8001 Zürich, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2015

  • Number of employees in Switzerland

    1-9

Key business